Amlodipine Besylate Tablet
Product Images NDC 76282-239

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 76282-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

A Kaplan-Meier curve comparing event rates over 24 months for Amlodipine versus placebo. The graph shows lower event rates for Amlodipine with a hazard ratio of 0.691 and a p-value of 0.003. Time is plotted in months on the x-axis, and event rate on the y-axis, with the number at risk indicated below.*

FDA Label Image

Fig2 (Fig2)

A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine to placebo across various patient subgroups such as age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI stent strata. The x-axis represents hazard ratios from 0.0 to 2.0, centered at 1.0 (line of no effect).*

FDA Label Image

Structure (Ima)

Chemical structure of amlodipine besylate, showing the molecular arrangement of atoms including chlorine, oxygen, nitrogen, sulfur, and carbon groups as part of the compound's chemical makeup.*

FDA Label Image

Image10mg (Ima10mg)

Label for Amlodipine Besylate Tablets USP 10 mg by Exelan Pharmaceuticals, Inc. The label indicates a package of 90 oral tablets, includes storage instructions (20°C to 25°C, protect from light), and manufacturing information (InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd., Hauppauge, NY). The label also contains barcode and QR code elements.*

FDA Label Image

Image2.5mg (Ima2.5)

Amlodipine Besylate Tablets, USP 2.5 mg oral tablets label from Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-237-90 and indicates a package size of 90 tablets. Storage instructions specify keeping the product at 20°C to 25°C (68°F to 77°F) and protecting it from light. The label also notes that each tablet contains 2.5 mg amlodipine equivalent and states the medication is Rx only.*

FDA Label Image

Image5mg (Ima5)

Label for Amlodipine Besylate Tablets USP, 5 mg strength, manufactured for Exelan Pharmaceuticals, Inc. The label indicates a package of 90 tablets and includes storage instructions, protective storage warnings, and manufacturing information for InvaGen Pharmaceuticals, Inc., a Cipla subsidiary. The label also features a barcode and QR code for identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.